Castle Biosciences
CSTL
CSTL
185 hedge funds and large institutions have $737M invested in Castle Biosciences in 2024 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 76 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 159 → 185 (+26)
1.68% more ownership
Funds ownership: 91.41% → 93.09% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
185
Holding in Top 10
4
Calls
$8.7M
Puts
$921K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$7.3M | |
| 3 | +$5.76M | |
| 4 |
Renaissance Technologies
New York
|
+$5.36M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.88M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$18.1M | |
| 3 | -$14.3M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.11M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$5.46M |